Fidelity Investments’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-45
Closed -$134 5585
2024
Q3
$134 Buy
+45
New +$133 ﹤0.01% 5063
2023
Q3
Sell
-152
Closed -$809 5298
2023
Q2
$809 Sell
152
-554
-78% -$3.55K ﹤0.01% 4743
2023
Q1
$4.37K Buy
706
+586
+488% +$4.72K ﹤0.01% 4429
2022
Q4
$1.55K Buy
120
+63
+111% +$1.16K ﹤0.01% 4566
2022
Q3
$1K Buy
57
+50
+714% +$1.52K ﹤0.01% 4635
2022
Q2
$0 Buy
+7
New +$569 ﹤0.01% 4953
2022
Q1
Sell
-64,460
Closed -$3.3M 4996
2021
Q4
$3.3M Hold
64,460
﹤0.01% 2459
2021
Q3
$4.56M Hold
64,460
﹤0.01% 2393
2021
Q2
$6.56M Buy
+64,460
New +$6.53M ﹤0.01% 2254

Other funds holding CELU

Fidelity Investments's CELU Position: Q4 2024 in Review

Fidelity Investments sold out of Celularity (CELU) in Q4 2024, closing a stake of 45 shares — an estimated $134 sold.

Fidelity Investments first reported a position in CELU in Q2 2021 and held it in 9 quarters. The position peaked at $6.56M in Q2 2021. 32 funds tracked by Wall St. Rank hold CELU as of Q4 2024.

  • Fidelity Investments reported no remaining Celularity position as of Q4 2024 after selling out during the quarter.
  • Fidelity Investments sold 45 Celularity shares in Q4 2024, an estimated $134.
  • Fidelity Investments first reported a position in Celularity in Q2 2021 and held it in 9 quarters.
  • Fidelity Investments's Celularity position peaked at $6.56M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Celularity as of Q4 2024.

Based on Fidelity Investments's 13F filing for Q4 2024, filed 13 Feb 2025.